QQQ   293.72 (+0.12%)
AAPL   148.31 (+0.19%)
MSFT   254.69 (-0.18%)
META   120.44 (+1.98%)
GOOGL   100.99 (+0.00%)
AMZN   95.50 (-1.08%)
TSLA   194.70 (+0.00%)
NVDA   171.35 (+1.25%)
NIO   12.09 (-5.40%)
BABA   85.94 (-1.85%)
AMD   77.48 (-0.19%)
T   19.19 (-0.47%)
MU   55.49 (-3.75%)
CGC   3.93 (+8.56%)
F   14.08 (+1.29%)
GE   85.26 (-0.83%)
DIS   98.59 (+0.74%)
AMC   8.17 (+13.00%)
PYPL   78.53 (+0.15%)
PFE   51.08 (+1.90%)
NFLX   316.95 (+3.74%)
QQQ   293.72 (+0.12%)
AAPL   148.31 (+0.19%)
MSFT   254.69 (-0.18%)
META   120.44 (+1.98%)
GOOGL   100.99 (+0.00%)
AMZN   95.50 (-1.08%)
TSLA   194.70 (+0.00%)
NVDA   171.35 (+1.25%)
NIO   12.09 (-5.40%)
BABA   85.94 (-1.85%)
AMD   77.48 (-0.19%)
T   19.19 (-0.47%)
MU   55.49 (-3.75%)
CGC   3.93 (+8.56%)
F   14.08 (+1.29%)
GE   85.26 (-0.83%)
DIS   98.59 (+0.74%)
AMC   8.17 (+13.00%)
PYPL   78.53 (+0.15%)
PFE   51.08 (+1.90%)
NFLX   316.95 (+3.74%)
QQQ   293.72 (+0.12%)
AAPL   148.31 (+0.19%)
MSFT   254.69 (-0.18%)
META   120.44 (+1.98%)
GOOGL   100.99 (+0.00%)
AMZN   95.50 (-1.08%)
TSLA   194.70 (+0.00%)
NVDA   171.35 (+1.25%)
NIO   12.09 (-5.40%)
BABA   85.94 (-1.85%)
AMD   77.48 (-0.19%)
T   19.19 (-0.47%)
MU   55.49 (-3.75%)
CGC   3.93 (+8.56%)
F   14.08 (+1.29%)
GE   85.26 (-0.83%)
DIS   98.59 (+0.74%)
AMC   8.17 (+13.00%)
PYPL   78.53 (+0.15%)
PFE   51.08 (+1.90%)
NFLX   316.95 (+3.74%)
QQQ   293.72 (+0.12%)
AAPL   148.31 (+0.19%)
MSFT   254.69 (-0.18%)
META   120.44 (+1.98%)
GOOGL   100.99 (+0.00%)
AMZN   95.50 (-1.08%)
TSLA   194.70 (+0.00%)
NVDA   171.35 (+1.25%)
NIO   12.09 (-5.40%)
BABA   85.94 (-1.85%)
AMD   77.48 (-0.19%)
T   19.19 (-0.47%)
MU   55.49 (-3.75%)
CGC   3.93 (+8.56%)
F   14.08 (+1.29%)
GE   85.26 (-0.83%)
DIS   98.59 (+0.74%)
AMC   8.17 (+13.00%)
PYPL   78.53 (+0.15%)
PFE   51.08 (+1.90%)
NFLX   316.95 (+3.74%)
NASDAQ:MLND

Millendo Therapeutics - MLND Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$1.42
$1.62
50-Day Range
$3.06
$5.84
52-Week Range
$0.92
$16.95
Volume
8,348 shs
Average Volume
1.52 million shs
Market Capitalization
$30.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MLND stock logo

About Millendo Therapeutics (NASDAQ:MLND) Stock

As of June 25, 2021, Millendo Therapeutics, Inc. was acquired by Tempest Therapeutics Inc., in a reverse merger transaction. Millendo Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Ann Arbor, Michigan.

Receive MLND Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Millendo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

MLND Stock News Headlines

Shark Tank Millionaire's Pick - This Tech Stock Could Take Off
We’ve seen this technology being pitched on ABC’s Shark Tank, and one of the investors made one of the biggest investments in the show’s history. We see time drawing nearer when this technology hits the mainstream so our team of analysts at The Motley Fool felt it was time to offer a special report. One Stock for the Self-Driving Revolution: This report is FREE when you sign up for Stock Advisor. pixel
Clearmind Announces Pre-IND Meeting Date with FDA
See More Headlines

Receive MLND Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Millendo Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:MLND
CIK
N/A
Fax
N/A
Employees
12
Year Founded
N/A

Profitability

Net Income
$-36,410,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.78 per share

Miscellaneous

Free Float
N/A
Market Cap
$30.43 million
Optionable
Optionable
Beta
0.48














MLND Stock - Frequently Asked Questions

What other stocks do shareholders of Millendo Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Millendo Therapeutics investors own include Allena Pharmaceuticals (ALNA), Matinas BioPharma (MTNB), VYNE Therapeutics (VYNE), Acasti Pharma (ACST), Onconova Therapeutics (ONTX), TherapeuticsMD (TXMD), Bionano Genomics (BNGO), DURECT (DRRX), Geron (GERN) and Heat Biologics (HTBX).

What is Millendo Therapeutics' stock symbol?

Millendo Therapeutics trades on the NASDAQ under the ticker symbol "MLND."

What is Millendo Therapeutics' stock price today?

One share of MLND stock can currently be purchased for approximately $1.60.

How much money does Millendo Therapeutics make?

Millendo Therapeutics (NASDAQ:MLND) has a market capitalization of $30.43 million.

How can I contact Millendo Therapeutics?

The official website for the company is www.millendo.com. The company can be reached via phone at 734 845 9000.

This page (NASDAQ:MLND) was last updated on 12/1/2022 by MarketBeat.com Staff